The recent identification of human placental lactogen (HPL), a polypeptide hormone which shares both biological and immunological properties with pituitary growth hormone (HGH), has led to much speculation concerning its physiological role in pregnancy and potential usefulness as a therapeutic substitute for HGH.' Although the two proteins show partial immunological identity, purified HGH causes prominent lactogenic and somatotrophic effects,2 while HPL is predominantly lactogenic." 3 4 Since the complete amino acid sequence of HGH has recently been determined,5 and studies6-8 have suggested that HPL resembles HGH in molecular weight and amino acid composition, a detailed comparison of their chemical similarities was initiated. In the current study, each of the tryptic peptides of highly purified and biologically active HPL was isolated and its amino acid composition determined. Striking homologies in structure with most of the tryptic peptides of HGH were noted and indicated a strong biochemical basis for the physiological properties shared by the two hormones.
Biological assays: (a) Weight gain in hypophysectomized rats: Hypophysectomized male rats (Charles River) weighing an average of 100 gm were given daily subcutaneous injections with 5.3-and 9.9-mg quantities of purified HPL for periods of 7, 10 , and 14 days (assays were kindly performed by Dr. Charles Breuer of Lederle Laboratories).6 (b) Midpregnant rabbits were injected with HPL for 4 days in doses varying between 1 and 10 mg (peak B highly purified protein). Reactions were graded by the method proposed by Friesen.3 Immunological assays: (a) Agar gel diffusion studies by the Ouchterlony technique were performed in plastic Petri dishes using 0.7% agar Noble. (b) Radioimmunoassay studies were performed with purified HPL or growth hormone (preparation HS 612A-gift of Dr. A. E. Wilhelmi and National Pituitary Agency) which was labeled with 1131 by a modification of the method of Greenwood et al." The labeled hormones were separated from "damaged hormone" and free iodide on small columns of DEAE-cellulose. Antibodies to HPL were obtained by injection of partially purified HPL in adjuvant into guinea pigs, and growth hormone antiserum was a gift of Dr. Solomon A. Berson and the National Pituitary Agency. Bound and free hormone were separated by chromatoelectrophoresis on Whatman 3MC paper as described by Glick et al.12 or by a modification"3 of the dextran-coated charcoal method of Herbert et al. '4 Chemical studies: Purified HPL was subjected to acid hydrolysis in 6 N constant boiling HCl 2307 PROC. N. A. S.
in sealed evacuated tubes for periods of 24, 48, and 72 hr (values for each amino acid were averaged or extrapolated).'5 The calculation of half-cystine and methionine content was based on hydrolysis of -samples treated with performic acid, and the tryptophan-containing peptide was identified by Ehrlich stain.'6 Reduction and alkylation of the disulfide bonds were performed by previously described methods.'7 One gram of purified HPL (peak B) was dissolved in 100 cc of freshly prepared 10 M urea and 7 cc of beta-mercaptoethanol; the solution was made slightly alkaline with ammonium hydroxide and was incubated under nitrogen at 370 for 2 hr. After precipitation in cold acid alcohol, the reduced protein was centrifuged at 10,000 rpm for 20 min. The precipitate was resuspended in 40 cc of 10 M urea to which 1 gm of recrystallized C'4-iodacetic acid (Volk Chemical) was added and the pH raised to 8.5 with ammonium hydroxide. After 10 min, the reaction was terminated by addition of a large excess of mercaptoethanol. After precipitation with acid-alcohol, the protein was centrifuged and washed. A small portion of the alkylated derivative was subjected to gel filtration on Sephadex G-100 (column size 25 X 1 cm) in 0.2 M formic acid to ensure homogeneity of the reduced, alkylated product. Likewise, 1 mg of protein was subjected to amino acid analysis after acid hydrolysis to ensure complete conversion of cysteine to S-carboxymethylcysteine.
Reduced and alkylated HPL (900 mg) was dissolved in 100 cc of 0.2 M ammonium bicarbonate to which 10 mg of trypsin in 1 cc of 0.001 M HC1 was added. The solution was incubated with gentle stirring at 370 for 1 hr, following which an identical aliquot of trypsin was added for a second hour of incubation. After lyophilization, the tryptic peptide mixture was dissolved in 0.2 M formic acid and loaded on a jacketed (50'C) column of Dowex 50-X2 (160 X 2.5 cm) that was equilibrated with pyridine formate buffer (0.2 M, pH 2.8). The column was pumped at 50 cc per hour, and the peptides were eluted with a four-bottle gradient system comprising one liter each of pyridine formate 0.2 M (pH 2.8), 0.3 M (pH 3.4), and pyridine acetate 0.5M (pH 4.5), 0.9 M (pH 5.5). After completion of the gradient, two liters of sodium phosphate 0.4 M (pH 9.5) were passed over the column to ensure removal of any strongly basic peptides. Alternate tubes were analyzed for pH, radioactivity, and for ninhydrin color (at 570 m/A) after alkaline hydrolysis.18
The eluate was divided arbitrarily into 26 fractions on the basis of ninhydrin color; each fraction was analyzed after lyophilization by analytical high-voltage electrophoresis (Gilson electrophorator) for 4 hr in pyridine acetate buffer (pH 3.6, 0.2 M). Preparative electrophoresis was performed on those fractions containing significant peptides, and these were eluted from Whatman 3 paper by acetic acid and ammonia. After hydrolysis, amino acid analyses of the peptides were performed on a Beckman 120B automatic amino acid analyzer equipped with a digital integrator (Infotronics Corp.).
Results.-When partially purified HPL was subjected to gel filtration on Sephadex G-100, two protein peaks were observed (Fig. 1) , one at the void volume (peak A) and a second larger peak which was eluted with a Kd of 0.4 (peak B). A variety of studies indicated that peak B represented pure HPL6 and possessed biological, immunological, and chemical properties which were similar to the hormone prepared by previous workers.'-'
The purified hormone possessed full biological activity as assessed by (1) weight gains in hypophysectomized rats which were equivalent to those observed in previous studies,6 and (2) production of a 3 or 4+ lactational response3 in all pregnant rabbits tested, with no reaction being observed in the saline-treated controls. Furthermore, the immunological potency was identical to that of a highly purified sample provided by Dr. Henry Friesen (preparation 98A 51-55) when tested by radioimmunoassay. Peak B was analyzed carefully for further evidence of chemical homogeneity: (a) Gel filtration on Sephadex G-100 before and after reduction and alkylation showed it to be completely homogeneous; (b) previous studies6 in the ultracentrifuge indicated a single peak in 5 M guanidine with a molecular weight of 19,000; (c) agar gel diffusion studies of B against antiserum to crude HPL (5%) showed a single immunoreactive band, while the same antiserum produced several bands with the crude protein; and (d) polyacrylamide disc gel electrophoresis indicated that two rapidly moving electrophoretic bands were present in the purified material, the slower band being the dominant one (Fig. 3 ).
Before proceeding with a detailed structural analysis of peak B, it was necessary to ascertain purity by determining the chemical nature of the two electrophoretic bands. Attempts were made to resolve them by chromatography on DEAE-cellulose in a variety of solvent systems, but only partial resolution could be obtained. The technique of preparative acrylamide electrophoresis was therefore utilized to achieve separation. Although the two bands were resolved only partially (Fig. 2) , a sufficient amount of pure material of each type was obtained from the leading (tube No. 19) and trailing edges (tube No. 27) of the elution pattern to allow further studies.
Immunological studies of the proteins in tubes 19 and 27 were of two types: (a) Equivalent concentrations of each protein (0.5 mg/ml) were studied in agar gel diffusion against antiserum to HGH (Fig. 4) . A single immunoreactive band was noted between HGH and its homologous antibody; peak B (HPL) showed a partial reaction of identity with HGH, and peak A (Fig. 1) showed no reaction. The protein in tubes 19 and 27 demonstrated a line of identity which was similar to the reaction with B. (b) A radioimmunoassay employing J'31-HGH and antiserum to HGH indicated that the two proteins produced a partial but equivalent displacement of 1131-HGH bound to specific antibody.
When polyacrylamide disc gel electrophoresis was performed at pH 4.4, the two bands were closer in electrophoretic mobility. Following prolonged incubation of B protein in 0.2 N sodium hydroxide at room temperature, the faster-moving component (N~o. 19 ) increased in quantity, and bands with even greater mobility were The amino acid composition of purified HPJL is shown in Table 1 . The minimum hormone and ovine prolactin. 19 The results of these studies ascertained the purity of peak B and permitted a more detailed chemical investigation of the hormone to be initiated. amino acid content was estimated on the basis of a molecular weight of 19,000, and striking similarities in the amino acid composition of HPI and HGH NN ere noted.6 7 Although the total content of glutamic and aspartic acid residues in the hormones was similar, HPL must have fewer amide groups, since its electrophoretic mobility at pH 9.3 was much greater.
The tryptic peptides eluted from Dowex-50 (Fig. 5 ) were separated into 26 peaks which, on analytical electrophoresis, produced a series of 20 strongly reactive niinhydrin spots, corresponding well in number with the theoretical number of tryptic peptides predicted. Several of the larger peptides showed little or no mobility from the origin, and at least one peptide (T26) was ninhydrin-negative. The composition of the tryptic peptides is shown in Table 2 ; each peptide contained at least one arginine or lysine residue, except for T5A, which was the carboxyl-terminal peptide. Peptide T14A contained equimolar amounts of lysine and arginine and presumably represented incomplete cleavage at a site normally susceptible to digestion. The significant peptides obtained by trypsin digestion of HPL were compared with the tryptic peptides of growth hormone5 (Table 2) which vary in size from 1 to 23 residues and have unique compositions. Likewise, the 20 tryptic peptides of HPL showed unique characteristics in size and composition, and each could be related to a tryptic peptide in HGH whose amino acid composition was identical or quite similar. The compositions of tryptic peptides T17a, 8a, 7a, 16a, 12d, 14a, and 5a in HPL were identical to peptides in HGH, while the compositions of pep-PROC. N. A. S. tides T18c, 24, 18, 7b, 9b, 16c, 20d, and 13c differed by no more than one to three residues from similar peptides in HGH. The remaining peptides T26, 12, 6b, and 13b, which showed more significant differences, did, however, show enough similarities to HGH peptides to be tentatively placed in homologous regions (the yields of peptides T6b and 13b were small (Table 2) , and their assignment is tentative). The four cysteine peptides were clearly identified by their radioactivity and amino acid composition, and preliminary studies with fragments of HPL obtained from cleavage of HPL with cyanogen bromide2O indicate that the disulfide bonds of HPL are in the same location as the corresponding ones of HGH. Furthermore, the cyanogen bromide data confirm the tentative alignment of the HPL peptides listed in Table 2 . Discussion.-The chemical properties of purified HPL have been determined in the current study and compared with those of HGH in order to define the biochemical basis for the similarities and differences in behavior of the two hormones. Placental lactogen and HGH share a number of physical and chemical properties:
(1) molecular weight and tendency to aggregate in solution, (2) highly acidic charge with rapid mobility in electrophoresis at pH 9.3, (3) tendency to undergo deamidation with production of electrophoretic heterogeneity, (4) striking similarities in amino acid composition, and (5) a pair of disulfide bonds which are probably in the same three-dimensional configuration. Detailed analysis of the tryptic peptides obtained from reduced, alkylated HPI, indicate, furthermore, that the two proteins have substantial similarities in chemical structure, since each of the tryptic peptides of HPL appears to be related to an identical or very similar peptide in HGH. Although the current studies have not yet confirmed the exact location of each tryptic peptide in HPL, the preliminary results of cyanogen bromide cleavage20 and Comparison of the amino acid composition of the tryptic peptides of HGH with the apparently homologous peptides of HPL. A single asterisk (*) indicates that the composition of the HPL peptide was identical with a peptide in HGH, while a double asterisk (**) indicates that they differed by no more than one to three residues. Peptide T14a of HPL contained equimolar amounts of lysine and arginine due to failure of cleavage at one site, but its total composition was equivalent to the adjacent HGH peptides 17 and 18.
The numbers in parenthesis (times 10-2) are recoveries obtained from paper elution following preparative electrophoresis of approximately 1 uM of each peptide. Peptides T6b and 13b were obtained in relatively low yield, and their assignment is tentative. The total amino acid composition obtained by addition of the residues from each peptide is shown in Table 1 and compares favorably with the theoretical composition.
the marked homologies with HGH peptides indicate that the tentative assignments are probably correct. Catt et al.2' have recently determined the amino acid sequence of a small portion of HPL at the amino terminus and indicated similarities in location of 11 of 17 residues in the two hormones. The current studies confirm these findings and indicate, moreover, that the similarities in the rest of the peptide chain are even more striking, particularly for HGH peptides 10-20.
The homologies in chemical structure between a pituitary and placental hormone are intriguing and suggest that the two proteins are probably descendants of a common ancestral polypeptide. With evolution these molecules have been modified by genetic substitutions so that a dissociation in biological potency exists, with HGH possessing both lactogenic and somatotrophic activities, while HPL is predominantly lactogenic. The molecular features responsible for these two activities may be present in different portions of the polypeptide chain, a factor that may explain the dichotomy in biological effects.
While it has been possible in the case of certain protein enzymes to define an "active site" and to suggest molecular mechanisms of enzyme action, neither the hormone equivalent of an active site nor the nature of the tissue receptor for hormones has been clearly identified. Recent studies have indicated, however, that polypeptide hormones probably act at the cell membrane,22 and that the entire polypeptide chain may not be necessary for the biological effects of such hormones. 23 For these reasons, it is most important to identify the biologically active regions of these two proteins and to determine whether the differences in biological and immunological activity are the result of differences in protein conformation or in a vital residue(s) in the active portion of the molecule. As the complete amino acid sequence of HPL is determined, such information should become available, and may suggest how a molecular subfragment of HPL could be modified to increase its somatotrophic effects enough to make it a useful and urgently needed substitute for the limited supplies of HGH. Further chemical studies of HPL and related lactogenic hormones should help to explain the apparent physiological and evolutionary similarities between two such diverse organs as the pituitary gland and the placenta.
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